Media coverage

This is a selection of external articles about Isofol. Source: Meltwater AB

About Isofol

Isofol Medical AB (publ) is a biotech company within the field of oncology developing arfolitixorin, primarily as a treatment for advanced colorectal cancer and as a rescue drug after high-dose methotrexate treatment in osteosarcoma (bone cancer).

Contact

Isofol Medical AB (publ)
Biotech Center, Arvid Wallgrens Backe 20
SE-413 46 Gothenburg
Sweden

Phone: +46 (0)31 7972280
E-mail: info@isofolmedical.com

Newsletter and Privacy Policy

Sign up here to receive information and news and agree to Isofol’s processing of your personal data according to the company’s Integrity.
Isofol´s Integrity Policy (general)
Isofol´s Integrity Policy (clinical studies)

Isofol´s Glossary